Back to Search
Start Over
Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas.
- Source :
-
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia [Rev Bras Ginecol Obstet] 2019 May; Vol. 41 (5), pp. 357-359. Date of Electronic Publication: 2019 Jun 10. - Publication Year :
- 2019
-
Abstract
- Competing Interests: The authors are employed by Becton Dickinson and Company, which sells and distributes cervical cancer screening products, including the BD Onclarity HPV Assay (Becton Dickinson, Franklin Lakes, NJ, USA), which targets the E6/E7 region of the HPV genome.
Details
- Language :
- English
- ISSN :
- 1806-9339
- Volume :
- 41
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31181587
- Full Text :
- https://doi.org/10.1055/s-0039-1688710